Aquestive Therapeutics, Inc. — Director's Dealing 2018

Jul 25, 2018

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Aquestive Therapeutics, Inc. (AQST)
CIK: 0001398733
Period of Report: 2018-07-24

Reporting Person: Marshall Ken W. (N/A)

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Option (right to purchase)	$6.54	2028-04-18	Common Stock (19997)		Direct

Footnotes

F1: This option, representing a right to purchase a total of 19,997 shares of Common Stock, was granted April 18, 2018. The shares underlying such option vest as follows: 25% vest on the first anniversary of the grant date, 25% vest on the second anniversay of the grant date and the remaining 50% vest on the third anniversary of the grant date, subject in each case to Mr. Marshall's continuous service with the Issuer through the applicable vesting date.